Yatsen Holding Ltd ADR Dossier
|
SectorConsumer Staples IndustryPersonal Care Products Beta (adjusted)-0.70 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $2.78Price as of 30 Sep 2026 Data confidence Sign in to view data confidence Market Cap $260.8M Shares Outstanding 93.8M diluted Moat Rating None Next Earnings Date17 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Yatsen Holding Limited is successfully executing a strategic pivot from its legacy, low-margin mass color cosmetics business (led by Perfect Diary) toward premium and clinical skincare brands (such as Galénic, DR.WU, and Eve Lom). This transition has driven gross margins to a record 80.2% in Q1 2026. However, the company continues to face elevated customer acquisition costs and intense competition in China's beauty market, resulting in widened operating losses. While long-term backing from major institutional investors like Hillhouse and Trustar Capital provides capital stability, a 'Hold' recommendation is warranted until the company demonstrates a sustainable path to GAAP operating profitability. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$4.01 Mean target$4.01 High · most bullish analyst$4.01 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $2.0020% Color cosmetics experience a sharper-than-expected decline, while customer acquisition costs for the skincare segment rise further due to intense competition on short-video platforms. Gross margins contract and cash burn accelerates, forcing reliance on debt or dilutive financing. Base CaseCentral scenario $3.5050% Skincare brands remain the primary growth engine, maintaining a 50%+ share of total revenue. Gross margins stabilize around 80%, but high selling and marketing expenses persist, keeping the company near breakeven on a non-GAAP basis while GAAP net losses narrow gradually. Bull CaseUpside scenario $4.5030% The premium skincare portfolio continues to grow at a >50% YoY rate, successfully offsetting the decline in color cosmetics and lifting the consolidated gross margin above 82%. Operating leverage kicks in as brand equity reduces the reliance on paid traffic, leading to sustained GAAP profitability. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |